XML 43 R6.htm IDEA: XBRL DOCUMENT  v2.3.0.11
CONDENSED CONSOLIDATED STATEMENT OF EQUITY (unaudited) (USD $)
In Thousands, except Share data
3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2011
Jun. 30, 2011
Balances, at beginning of period   $ 1,059,997 $ 1,068,629
Balances, at beginning of period (in shares)   124,316,545 124,408,574
Compensation expense related to restricted stock and restricted stock unit grants 4,555 9,095  
Net loss (33,959) (46,264)  
Equity component of convertible notes, net   76,835  
Purchase of bond hedge (77,007) (77,007)  
Issuance of warrants 45,066 45,066  
Issuance of common stock under Associate Stock Purchase Plan   520  
Restricted stock, net   0  
Unrealized (loss) gain on marketable securities - restricted   221  
Reclassification of net gains on derivatives into earnings 114 228  
Amortization of payments from settlement of forward interest rate swaps 94 188  
Other   (250)  
Common Stock [Member]
     
Balances, at beginning of period   1,243 1,244
Balances, at beginning of period (in shares)   124,317,000 124,409,000
Compensation expense related to restricted stock and restricted stock unit grants   0  
Net loss   0  
Equity component of convertible notes, net   0  
Purchase of bond hedge 0 0  
Issuance of warrants 0 0  
Issuance of common stock under Associate Stock Purchase Plan   0  
Issuance of common stock under Associate Stock Purchase Plan (in shares)   22,000  
Restricted stock, net   1  
Restricted stock, net (in shares)   70,000  
Unrealized (loss) gain on marketable securities - restricted   0  
Reclassification of net gains on derivatives into earnings   0  
Amortization of payments from settlement of forward interest rate swaps   0  
Other   0  
Additional Paid-in Capital [Member]
     
Balances, at beginning of period   1,904,144 1,958,652
Compensation expense related to restricted stock and restricted stock unit grants   9,095  
Net loss   0  
Equity component of convertible notes, net   76,835  
Purchase of bond hedge (77,007) (77,007)  
Issuance of warrants 45,066 45,066  
Issuance of common stock under Associate Stock Purchase Plan   520  
Restricted stock, net   (1)  
Unrealized (loss) gain on marketable securities - restricted   0  
Reclassification of net gains on derivatives into earnings   0  
Amortization of payments from settlement of forward interest rate swaps   0  
Other   0  
Treasury Stock [Member]
     
Balances, at beginning of period   (29,187) (29,187)
Compensation expense related to restricted stock and restricted stock unit grants   0  
Net loss   0  
Equity component of convertible notes, net   0  
Purchase of bond hedge 0 0  
Issuance of warrants 0 0  
Issuance of common stock under Associate Stock Purchase Plan   0  
Restricted stock, net   0  
Unrealized (loss) gain on marketable securities - restricted   0  
Reclassification of net gains on derivatives into earnings   0  
Amortization of payments from settlement of forward interest rate swaps   0  
Other   0  
Retained Earnings [Member]
     
Balances, at beginning of period   (815,876) (862,140)
Compensation expense related to restricted stock and restricted stock unit grants   0  
Net loss   (46,264)  
Equity component of convertible notes, net   0  
Purchase of bond hedge 0 0  
Issuance of warrants 0 0  
Issuance of common stock under Associate Stock Purchase Plan   0  
Restricted stock, net   0  
Unrealized (loss) gain on marketable securities - restricted   0  
Reclassification of net gains on derivatives into earnings   0  
Amortization of payments from settlement of forward interest rate swaps   0  
Other   0  
Accumulated Other Comprehensive Income (Loss) [Member]
     
Balances, at beginning of period   (327) 60
Compensation expense related to restricted stock and restricted stock unit grants   0  
Net loss   0  
Equity component of convertible notes, net   0  
Purchase of bond hedge 0 0  
Issuance of warrants 0 0  
Issuance of common stock under Associate Stock Purchase Plan   0  
Restricted stock, net   0  
Unrealized (loss) gain on marketable securities - restricted   221  
Reclassification of net gains on derivatives into earnings   228  
Amortization of payments from settlement of forward interest rate swaps   188  
Other   $ (250)